Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Podolec, J. Siekaniec (Cracow, Poland). Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB. Eur Respir J 2010; 36: Suppl. 54, 2029

Member's Comments

No comment yet.

Related content which might interest you: Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Effective and efficient nebulization of alpha1-proteinase inhibitor (alpha1-PI) for inhalation therapy using the AKITA2® APIXNEBÔ nebulizer system Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Endogenous particles in exhaled air – Variability of particle number in healthy individuals Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Effect of nebuliser position on aerosol performance during high flow nasal therapy Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018 Particle size and gravimetric characteristics of Clenny Aerosol, a new jet nebulizer with breath enhanced bulb Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001 LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006 Effect of I:E ratio on the respirable delivered dose from nebulizers Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 The influence of inhalation flow and aerosol size on deposition: modelled vs. clinical data Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Effect of antistatic AeroChamber Plus® Flow-Vu® spacer on the systemic bioavailability of CHF5993 a novel triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Comparison of aerosol delivery of AccuMist and AeroEclipse II using a breath simulator Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Aerosol particle size output from a new nebuliser system, measured by cascade impaction Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005 Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): Influence on lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Lung targeting of flunisolide is enhanced when delivered as an extra fine HFA aerosol with a built-in spacer Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001